This content is from: Premium
Cormorant Eyes Three IPOs This Week, Betting on Recent Success
More than a half-dozen firms, known for their hedge funds, have previously made investments in the biopharma companies.
This is a big week for the folks at Cormorant Asset Management.Three of its private holdings have set terms for their initial public offerings and are expected to begin trading in the next few days. Cormorant is a major investor in two of the three companies and a smaller investor
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.